Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldConference

GMP and Regulatory Expectations for Early IND Products 2017

GMP and Regulatory Expectations for Early IND Products 2017

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Directors, Managers, Supervisors, and lead workers in Regulatory Affairs, Quality Assurance and Quality Control Workers who will prepare GMP documents for early phase products as well as those who will review these documents Regulatory affairs workers who will need to deal with submissions covering early phase products

Details

Course "GMP and Regulatory Expectations for Early IND Products" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

 

Overview:

 

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials.

 

Why should you attend:

 

Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware of the regulatory requirements that will affect operations dealing with these products. The modifications to the GMPs for early phase products have modified the GMPs in such a way as to reduce requirements to allow more efficient work. At the same time some of the things that may appear to have changed, have not, and the pharmaceutical worker should be aware of this.

 

Who will benefit:

 

  • Directors, Managers, Supervisors, and lead workers in Regulatory Affairs, Quality Assurance and Quality Control
  • Workers who will prepare GMP documents for early phase products as well as those who will review these documents
  • Regulatory affairs workers who will need to deal with submissions covering early phase products

 

 

Location: Taipei, Taiwan Date:  November 13th & 14th, 2017 and Time: 9:00 AM to 6:00 PM

Venue: WILL BE ANNOUNCED SOON , Taipei, Taiwan

Price:

 

Price: $895.00 (Seminar Fee for One Delegate)

Register for 5 attendees   Price: $2,685.00   $4,475.00 You Save: $1,790.00 (40%)*

Register now and save $200. (Early Bird)

Until October 05, Early Bird Price: $895.00 From October 06 to November 11, Regular Price: $1,095.00

Register for 10 attendees   Price: $4,922.00  $8,950.00 You Save: $4,028.00 (45%)*

 

 

Contact us today!

 

NetZealous LLC DBA GlobalCompliancePanel

john.robinson@globalcompliancepanel.com  

support@globalcompliancepanel.com 

Toll free: +1-800-447-9407

Phone: +1-510-584-9661

 Website: http://www.globalcompliancepanel.com

 

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901321SEMINAR?pharmiweb-November-2017-SEO

 

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

Follow us on Twitter: https://twitter.com/GCPanel

 

 

 

Prices

Price: $895.00 (Seminar Fee for One Delegate) Register for 5 attendees Price: $2,685.00 $4,475.00 You Save: $1,790.00 (40%)* Register for 10 attendees Price: $4,922.00 $8,950.00 You Save: $4,028.00 (45%)* Register now and save $200. (Early Bird)

Contact

Event Manager
john.robinson@globalcompliancepanel.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.